Abstract:BackgroundDiabetic retinopathy is severe damage to the retina caused by complications of diabetes, and is the prevailing cause of blindness. Accumulating evidence from both animal models and humans suggests that the inflammatory process plays a key role in the development of diabetic retinopathy and is facilitated by innate immune response. The aim of this study was to examine whether the TLR4 signaling pathway was involved in the streptozotocin-induced diabetic rat retina.MethodsDiabetes was induced by a single intraperitoneal injection of streptozotocin, and rat diabetic retinopathy was examined at 4 weeks of diabetes duration. Then the accumulated leukocytes were counted in vivo by acridine orange leukocyte fluorography, and the retinal vascular permeability was measured by the Evans blue assay. The expressions of TLR4 and its downstream signaling molecules were measured by RT-PCR or Western blot respectively. To evaluate the effect of blocking TLR4 on diabetic retinopathy, TAK-242, a selective TLR4 antagonist, was administered by intraperitoneal injection.ResultsOur results showed that the retina of diabetic rats demonstrated accumulated leukocytes and retinal vascular permeability. The mRNA and protein expressions of TLR4 were upregulated in streptozotocin-treated diabetic rat retina. Furthermore, the protein levels of TLR4 downstream signaling molecules were significantly increased in streptozotocin-treated animals. In addition, the protein levels of tumor necrosis factor (TNF)-α, interleukin (IL)-1β, and interferon (IFN)-β, three downstream proinflammatory cytokines of TLR4 signal transduction pathway, were also markedly increased in diabetic rats. Administration of TAK-242 attenuated leukocytes accumulated and retinal vascular permeability, and decreased TLR4 downstream signaling molecules and proinflammatory cytokines in streptozotocin-induced animals.ConclusionsTogether, these data have demonstrated that TLR4 has a critical role in streptozotocin-induced diabetic retinopathy at the level of inflammatory cytokine induction, in both the MyD88-dependent and MyD88-independent pathways. TLR4 may become a new potential pharmacological target for treating diabetic retinopathy.

Toll-Like Receptor 4 Activation Contributes to Diabetic Bladder Dysfunction in a Murine Model of Type 1 Diabetes

Toll-like receptor 4-mediated hyper-responsiveness of gingival epithelial cells to lipopolysaccharide in high-glucose environments.

Toll-like receptor 4 promotes tubular inflammation in diabetic nephropathy

Toll-like Receptor 4 on Islet Β Cells Senses Expression Changes in High-Mobility Group Box 1 and Contributes to the Initiation of Type 1 Diabetes

Toll-Like Receptor 4 in Bone Marrow-Derived Cells Contributes to the Progression of Diabetic Retinopathy

T‐ and L‐Type Voltage‐Gated Calcium Channels: Their Role in Diabetic Bladder Dysfunction

The role of Toll-like receptor proteins (TLR) 2 and 4 in mediating inflammation in proximal tubules

Downregulation of <scp>BDNF–TrkB</scp> signaling may contribute to the colonic motility disorders in mice with streptozocin‐induced diabetes

Cannabinoid receptors 1 and 2 are associated with bladder dysfunction in an experimental diabetic rat model.

Functional, Structural, and Neuronal Alterations in Urinary Bladder during Diabetes: Investigations of a Mouse Model

Activation of the 5-hydroxytryptamine 4 receptor ameliorates tight junction barrier dysfunction in the colon of type 1 diabetic mice

MiR‐874 Alleviates Renal Injury and Inflammatory Response in Diabetic Nephropathy Through Targeting Toll‐like Receptor‐4

Expression of Transforming Growth Factor Beta1 Gene, Basic Fibroblast Growth Factor Gene and Hydroxyproline in Diabetes-Induced Bladder Dysfunction in a Rat Model.

Deletion of Nrf2 induced severe oxidative stress and apoptosis in mice model of diabetic bladder dysfunction

Differentially Expressed mRNA in Streptozotocin-Induced Diabetic Bladder Using RNA Sequencing Analysis

Association of the TLR4 signaling pathway in the retina of streptozotocin-induced diabetic rats

Toll-Like Receptor 2 Agonist Exacerbates Renal Injury in Diabetic Mice

Cross-talk between angiotensin-II and toll-like receptor 4 triggers a synergetic inflammatory response in rat mesangial cells under high glucose conditions.

Mechanisms of Action for Diabetic Bladder Dysfunction — State of the Art

CpG-ODN Activation of TLR9 Signaling Pathways and NF-κB in STZ-induced Diabetic Rats

Knockdown of TLR4 attenuates high glucose-induced podocyte injury via the NALP3/ASC/Caspase-1 signaling pathway.